A mouse/human-chimeric bispecific antibody reactive with human carcinoembryonic antigen-expressing cells and human T-lymphocytes

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2661-2667

  Kuwahara, Motohisa ^a   Kuroki, Masahide ^a   Arakawa, Fumiko ^a   Senba, Tarumi ^a   Matsuoka, Yuji ^a   Hideshima, Teru ^a   Yamashita, Yuichi ^a   Kanda, Hidetoshi ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b EIKEN CHEMICAL CO LTD   (Japan)

Author keywords

Carcinoembryonic antigen; CD3; Chimeric bispecific antibody; Immunotherapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BISPECIFIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN; CD3 ANTIGEN; CHIMERIC ANTIBODY;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL ADHESION; CELL KILLING; COLORIMETRY; CONTROLLED STUDY; CROSS LINKING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIGENS, CD3; CARCINOEMBRYONIC ANTIGEN; HUMANS; MICE; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0029911298     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Oikawa S, Nakazato H and Kosaki G: Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem Biophys Res Commun 142: 511-518, 1987.
2. Thompson JA, Grunelt F and Zimmermann W: Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J Clin Lab Anal 5: 344-366, 1991.
3. Benchimol S, Fuks A, Jothy S et al: Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327-334, 1989.
4. Kuroki Mo, Arakawa F, Yamamoto H et al: Active production and membrane anchoring of carcinoembryonic antigen observed in normal colon mucosa. Cancer Lett 43: 151-157, 1988.
5. Goldenberg DM: Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy. Tumor Biol 16: 62-73, 1995.
6. Staerz UD, Kanagawa O and Bevan MJ: Hybrid antibodies can target sites for attack by T cells. Nature 314: 628-631, 1985.
7. Liu MA, Kranz DM, Kurnick JT et al: Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes. Proc Natl Acad Sci USA 82: 8648-8652, 1985.
8. Segal DM and Snider DP: Targeting and activation of cytotoxic lymphocytes. Chem Immunol 47: 179-213, 1989.
9. Nitta T, Yagita H, Azuma T et al: Bispecific F(ab′)2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells. Eur J Immunol 19: 1437-1441, 1989.
10. Titus JA, Garrido MA, Hecht TT et al: Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice. J Immunol 138: 4018-4022, 1987.
11. Schroff RW, Foon KA, Beatty SM et al: Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 45: 879-885, 1985.
12. Shawler DL, Bartholomew RM, Smith LM et al: Human immune response to multiple injections of murine monoclonal IgG. J Immunol 135: 1530-1535, 1985.
13. Courtenay-Luck NS, Epenetos AA, Moore R et al: Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res 46: 6489-6493, 1986.
14. Morrison SL, Johnson MJ, Herzenberg LA et al: Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 81: 6851-6855, 1984.
15. Arakawa F, Haruno M, Kuroki Ma et al: Construction and expression of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen. Hybridoma 12: 365-379, 1993.
16. LoBuglio AF, Wheeler RH, Trang J et al: Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci USA 86: 4220-4224, 1989.
17. Haruno M, Kuroki Ma, Arakawa F et al: In vitro and in vivo characterization of two mouse-human chimeric antibodies with high specificity and affinity for carcinoembryonic antigen. Antibody Immunoconj Radiophar 7: 133-148, 1994.
18. Hoffman RA, Kung PC, Hansen WP et al: Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA 77: 4914-4917, 1980.
19. Bolt S, Routledge E, Lloyd I et al: The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur J Immunol 23: 403-411, 1993.
20. Kuroki Ma, Arakawa F, Haruno M et al: Biochemical characterization of 25 distinct carcinoembryonic antigen (CEA) epitopes recognized by 57 monoclonal antibodies and categorized into seven groups in terms of domain structure of the CEA molecule. Hybridoma 11: 391-407, 1992.
21. Wiemann MC, Dexter DL and Calabresi P: Artificial capillary culture studies of human tumor cell growth, differentiation, and marker production. J Natl Cancer Inst 79: 93-102, 1987.
22. Smith PK, Krohn RI, Hermanson GT et al: Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
23. Carlsson J, Drevin H, and Axén R: Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J 173: 723-737, 1978.
24. Karpovsky B, Titus JA, Stephany DA et al: Production of target-specific effector cells using hetero-cross-linked aggregates containing anti-target cell and anti-Fcγ receptor antibodies. J Exp Med 160: 1686- 1701, 1984.
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
26. Oikawa S, Inuzuka C, Kuroki Mo et al: Cell adhesion activity of non-specific crossreacting antigen (NCA) and carcinoembryonic antigen (CEA) expressed on CHO cell surface: homophilic and heterophilic adhesion. Biochem Biophys Res Commun 164: 39-45, 1989.
27. Kroesen BJ, Bakker A, van Lier RA et al: Bispecific antibody-mediated target cell-specific costimulation of resting T cell via CD5 and CD28. Cancer Res 55: 4409-4415, 1995.
28. Primus FJ, Finch MD, Masci AM et al: Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes. Cancer Res 53: 3355-3361, 1993.
29. Ikeda S, Kuroki Ma, Haruno M et al: Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese hamster ovary cells and 25 distinct monoclonal antibodies. Mol Immunol 29: 229-240, 1992.
30. Matsuoka Y, Matsuo Y, Okamoto N et al: Highly effective extraction of carcinoembryonic antigen with phosphatidylinositol-specific phospholipase C. Tumor Biol 12: 91-98, 1991.
31. Kuwahara M, Kuroki Ma, Haruno M et al: A rapid colorimetric assay for carcinoembryonic antigen (CEA)-mediated cell adhesion and analysis of CEA domains involved in the adhesion. Immunol Invest 23: 367-380, 1994.
32. Hussain RF, Nouri AME and Oliver RTD: A new approach for measurement of cytotoxicity using colorimetric assay. J Immunol Methods 160: 89-96, 1993.
33. Nitta T, Sato K, Yagita H et al: Preliminary trial of specific targeting therapy against malignant glioma. Lancet 335: 368-371, 1990.
34. Bolhuis RLH, Lamers CHJ, Goey SH et al: Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study. Int J Cancer Suppl 7: 78-81, 1992.
35. Songsivilai S, Clissold PM and Lachmann PJ: A novel strategy for producing chimeric bispecific antibodies by gene transfection. Biochem Biophys Res Commun 164: 271-276, 1989.
36. Shalaby MR, Shepard HM, Presta L et al: Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene. J Exp Med 175: 217-225, 1992.
37. De Sutter K and Fiers W: A bifunctional murine::human chimeric antibody with one antigen-binding arm replaced by bacterial ß-lactamase. Mol Immunol 31: 261-267, 1994.
38. Tada H, Kurokawa T, Seita T et al: Expression and characterization of a chimeric bispecific antibody againsl fibrin and against urokinase-type plasminogen activator. J Biotechnol 33: 157-174, 1994.